Activity of creatine kinase in sera from healthy women, carriers of Duchenne muscular dystrophy and cord blood, determined by the “European” recommended method with NAC-EDTA activation

1981 ◽  
Vol 116 (2) ◽  
pp. 209-216 ◽  
Author(s):  
D.W. Moss ◽  
Katrine B. Whitaker ◽  
C. Parmar ◽  
J. Heckmatt ◽  
J. Witkowski ◽  
...  
Author(s):  
A. C. Simpson ◽  
D. Holmes ◽  
R. J. T. Pennington

Dilution of serum before assay consistently increased the activity of serum creatine kinase both in normal female subjects and in carriers of Duchenne muscular dystrophy.


1982 ◽  
Vol 19 (1) ◽  
pp. 4-7 ◽  
Author(s):  
R F Gaines ◽  
S M Pueschel ◽  
E A Sassaman ◽  
J L Driscoll

1983 ◽  
Vol 62 (1-3) ◽  
pp. 171-180 ◽  
Author(s):  
Daisy Neves Falcão-Conceição ◽  
Marcia Mattos Gonçalves-Pimentel ◽  
Marcia Leite Baptista ◽  
Sônia Ubatuba

1977 ◽  
Vol 23 (12) ◽  
pp. 2341-2343 ◽  
Author(s):  
H L Verrill ◽  
N A Pickard ◽  
H D Gruemer

Abstract Currently, the most useful clinical laboratory aid in establishing the carrier state of Duchenne muscular dystrophy is to determine creatine kinase (EC 2.7.3.2) activity in the plasma. The considerable overlap between plasma creatine kinase activities of controls and of carriers at the childbearing age contributes appreciable difficulty to genetic counseling of potential carriers. The consistent failure of lymphocyte cap formation in Duchenne muscular dystrophy patients and carriers in this study suggests a valuable tool for the confirmation of the carrier state.


Sign in / Sign up

Export Citation Format

Share Document